Mark Crossley - Indivior PLC CFO, Director

IZQVFDelisted Stock  USD 23.94  0.35  1.44%   

Director

Mr. Mark Crossley serves as Chief Financial Officer, Executive Director of the Company. Indivior Chief Strategy Officer, Reckitt Benckiser Pharmaceuticals Inc. Global Finance Director, Procter and Gamble Associate Director Corporationrationrate Portfolio Finance, Procter and Gamble Associate Director Female Beauty Strategy and Business Planning, National Association of Corporationrationrate Directors Board Leadership Fellow. since 2017.
Tenure 8 years
Phone804 379 1090
Webhttps://www.indivior.com

Indivior PLC Management Efficiency

The company has return on total asset (ROA) of 0.0697 % which means that it generated a profit of $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.8557 %, meaning that it generated $0.8557 on every $100 dollars invested by stockholders. Indivior PLC's management efficiency ratios could be used to measure how well Indivior PLC manages its routine affairs as well as how well it operates its assets and liabilities.
Indivior PLC has accumulated 239 M in total debt with debt to equity ratio (D/E) of 1.22, which is about average as compared to similar companies. Indivior PLC has a current ratio of 1.67, which is within standard range for the sector. Debt can assist Indivior PLC until it has trouble settling it off, either with new capital or with free cash flow. So, Indivior PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Indivior PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Indivior to invest in growth at high rates of return. When we think about Indivior PLC's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

DIRECTOR Age

Ronald RichardEmergent Biosolutions
64
Kathryn ZoonEmergent Biosolutions
71
Sue BaileyEmergent Biosolutions
76
George JoulwanEmergent Biosolutions
80
Louis SullivanEmergent Biosolutions
86
Seamus MulliganEmergent Biosolutions
58
Breno OliveiraHypera SA
40
Jerome HauerEmergent Biosolutions
68
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia. Indiviorplc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 900 people. Indivior PLC [IZQVF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Indivior PLC Leadership Team

Elected by the shareholders, the Indivior PLC's board of directors comprises two types of representatives: Indivior PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Indivior. The board's role is to monitor Indivior PLC's management team and ensure that shareholders' interests are well served. Indivior PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Indivior PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jon Fogle, Chief Human Resource Officer
Nina DeLorenzo, Chief Officer
Jeffrey Burris, Chief Officer
Jason Thompson, VP Relations
Christian Heidbreder, Chief Scientific Officer and Head of RandD
Richard Simkin, Chief Commercial and Strategy Officer
Ryan Preblick, CFO Director
Mark Crossley, CFO, Director
Hillel West, Chief Officer
Cynthia Cetani, Chief Officer

Indivior Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Indivior PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Indivior Pink Sheet

If you are still planning to invest in Indivior PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Indivior PLC's history and understand the potential risks before investing.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets